Electrocautery Enhanced Delivery System Hold Huge Potential To Lower The Prevalence Of Walled Off Necrosis In Pancreatitis. North America To Witness The Highest Market Growth For The Device
Electrocautery Enhanced Delivery System Market is expected to exceed the market valuation of more than US$ XX million by 2027 expanding at a reasonable CAGR of around XX% during the forecast period (2021-2027). A frequent complication of acute pancreatitis is PFC, this can be classified as pancreatic pseudocysts (PP) and walled-off necrosis (WON). LAMS (Lumen-apposing metal stents) is reported as efficient in endoscopic transmural drainage of PP and WON. The benefits of LAMS in PFC is continually increasing. Additionally, with the arrival of the EC-LAMS (Electrocautery LAMS) technology, the efficacy of the treatment has been increased. In a recent meta-analysis included 14 studies from 2012-2016 among 812 patients (608 WON, 204 PP). For WON, the pooled technical success rate was 98.9% and the clinical success rate was 90%. For PP, the pooled technical success rate was 97% and the clinical success rate was 98%. In a multicenter study by Siddiqui et al. the endoscopic drainage and debridement of WON using LAMS was more efficient to the double-pigtail plastic stents (DPPS) terms. However, there was no difference in efficacy when compared with SEMS. However, the number of procedures required in LAMS were significantly lower than SEMS.
For a detailed analysis of the Electrocautery Enhanced Delivery System Market browse through – https://univdatos.com/report/eletrocautery-enhanced-delivery-system-market
Even with the current slowdown due to the covid impact the electrocautery enhanced delivery system devices market is estimated to grow. Key factors influencing the growth in the market include increase in surgeries count, rising prevalence of chronic diseases, lower risk od patient treatment, minimal invasive procedure, and lower mortality rate. Additionally, these devices have been approved by FDA for endoscopic visualization during pancreatic necrosis and pancreatic pseudocysts. Pancreatic pseudocysts and pancreatic necrosis are 2 types of pancreatic fluid collections occurring in 5-16% of the patients with acute pancreatitis and 20-40% of the patients with chronic pancreatitis. Along with this the increase in plastic and cosmetic surgeries, abdominal lipectomy, burn procedures, tendon repair, mammoplasty etc. are also increasing the growth in electrocautery enhanced delivery system market. A few drawbacks that may slow down the market growth include lack of skilled professionals, lack of awareness among patients, unavailability of supportive infrastructure and low technology penetration.
For a detailed analysis of the market drivers in Electrocautery Enhanced Delivery System Market browse through – https://univdatos.com/report/eletrocautery-enhanced-delivery-system-market
With the emergence of coronavirus in 2020, all surgical procedures and elective treatments were held at a standstill. Elective EC-LAMS procedures were stopped during the covid pandemic. However, a few studies have revealed a relation between Sars-CoV 2 (coronavirus) and chronic pancreatitis. In a study in China, out of 67 patients with severe covid-19, 12 patients had elevated amylase levels, 11 patients had elevated lipase levels and 5 patients had enlarged pancreas. Additionally, in a study in the United States, 14 (18.7%) out of 75 patients with Covid-19 met the criteria for acute pancreatitis. Even though these studies are small, and a clear correlation is still not confirmed, there are high chances that the coronavirus causes cases of pancreatitis.
Based on product, the Electrocautery Enhanced Delivery System Market is segmented into active electrode, dispersive electrode, and others. Amongst product, the dispersive electrode segment was valued at US$ XX million in 2020. Dispersive electrodes are used to safely remove electrosurgical energy from patients during monopolar electrosurgery. In the United States, the annual incidence of pancreatitis ranges from 4.9 to 35 per 100,000 population. This rate is increasing with the increase of obesity and gallstone, promoting the growth of the electrocautery enhanced delivery systems market. Smoking may also increase the rate of pancreatitis and thus the need for electrocautery procedures.
For a detailed analysis of the Application in the Electrocautery Enhanced Delivery System Market browse through – https://univdatos.com/report/eletrocautery-enhanced-delivery-system-market
Based on application the electrocautery enhanced delivery system market is segmented into cutting, coagulating, devitalization, and thermofusion. Thermofusion segment accounted for a market share of XX% in 2020. Electrocautery uses heat conduction using a direct electrical current. This can be accomplished by using DC from dry cells in a penlight type device. Acute pancreatitis can lead to mortality due to systemic inflammatory response syndrome and organ failure in the first two weeks after diagnosis due to sepsis and its complications. According to UpToDate, the overall mortality rate due to acute pancreatitis is 5% and mortality rates with interstitial and necrotizing pancreatitis is 3% and 17% respectively. Electrocautery devices is helpful in decreasing these mortality rates, and the increasing cases of pancreatitis are making the treatment more popular.
Based on end-user, the market is divided into hospitals, diagnostic centers, specialty clinics, and emergency ambulatory centers. The hospitals segment generated revenue of US$ XX million in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of US$ XX million by 2027F. The high revenue of hospitals lies in the fact that there are more caregivers present in the hospital. Additionally, electrocautery treatments require night stays for recovering as the patients are most vulnerable right after the surgery. Hospitals can provide the best care in the post-operative recovery procedures. Additionally, the diagnosis of acute pancreatitis is only made after an autopsy in 30-40% of the patients.
Request for Sample of the report browse through – https://univdatos.com/request_form/form/425
Additionally, the report provides detailed analysis for major regions including North America (the U.S, Canada, and Rest of North America), Europe (Germany, France, Spain, Italy, UK, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of Asia-Pacific), and the Rest of the World. North America dominated the market in 2020 with XX% share. Boston Scientific, McKesson Corporation, Symmetry Surgical, World Precision Instruments, Medline Industries, Inc., Medtronic Plc, Erbe Elektromedizian Gmbh, Smith and Nephew Plc, and Olympus Corporation are some of the prominent players operating in the global Electrocautery Enhanced Delivery System market. Several M&As along with partnerships have been undertaken by these players to expand their market reach.
Electrocautery Enhanced Delivery System Market Segmentation
Market Insight, by Product
- Active electrode
- Dispersive electrode
Market Insight, by Application
Market Insight, by End-User
- Diagnostic centers
- Specialty clinics
- Emergency ambulatory centers
Market Insight, by Region
- North America Electrocautery Enhanced Delivery System Market
- United States
- Rest of North America
- Europe Electrocautery Enhanced Delivery System Market
- United Kingdom
- Rest of Europe
- Asia-Pacific Electrocautery Enhanced Delivery System Market
- Rest of Asia-Pacific
- Rest of World Electrocautery Enhanced Delivery System Market
Top Company Profiles
- Boston Scientific
- McKesson Corporation
- Symmetry Surgical
- World Precision Instruments
- Medline Industries, Inc.
- Medtronic Plc
- Erbe Elektromedizian Gmbh
- Smith and Nephew Plc
- Olympus Corporation